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Background: Retroperitoneal hemorrhage (RPH) is a serious complication that occurs infrequently after PCI. This study aimed to compare the 
outcome of patients (pts) who developed RPH after PCI treated conservatively or invasively.
Methods: We identified 78 consecutive pts complicated with RPH after PCI confirmed by computed tomography (CT). The primary endpoint (MACE) 
was the composite of in-hospital mortality, myocardial infarction, and stroke.
Results: Among 11,129 pts, 78 (0.7%) presented a RPH confirmed by CT. Of these, 12 pts (15.4%) were treated medically without any blood 
product, 51 pts medically including transfusion (65.4%), and 15 pts invasively (19.2%) (12 by surgery, 3 percutaneously). The baseline clinical, 
angiographic and procedural characteristics were similar among the 3 groups. The magnitude of bleeding was greater for pts undergoing invasive 
strategy in terms of hematocrit drop and hemodynamic repercussion (Table). Two pts in the invasive cohort died (13.3%), both were bleeding related, 
and 4 pts in the conservative transfused cohort died (7.8%), 2 related to bleeding. The rate of MACE was similar between pts treated invasively 
compared to transfused pts managed conservatively (p= 0.29).
Conclusions: RPH remains as a serious complication and is related to high rates of mortality and morbidity. In this clinical series no difference in 
terms of ischemic and hemorrhagic outcomes was demonstrated using the invasive strategy compared to the non-invasive approach. 
In-hospital outcomes
Conservative strategy Invasive strategy
No transfusion
(n = 12)
Transfusion
(n = 51)
(n = 15) P value
Mean hematocrit drop, % ± SD 4.9 ± 5.0 11.3 ± 6.3 16.5 ± 6.9 <0.001
Hypotension, n (%) 4 (33.3) 22 (43.1) 12 (80) 0.02
Death, n (%) 0 4 (7.8) 2 (13.3) 0.58
Q-wave myocardial infarction, n (%) 0 3 (5.9) 0 0.99
Ischemic stroke, n (%) 0 1 (1.9) 1 (6.7) 0.57
Hemorragic stroke, n (%) 0 1 (1.9) 0 0.99
MACE, n (%) 0 9 (17.6) 3 (20) 0.29
Other source of bleeding, n (%) 0
2 (3.9)
(intracerebral, gastro-intestinal)
2 (13.3)
(gastro-intestinal, hematuria)
0.27
